首页> 外国专利> COMPOSITIONS FOR PREVENTING OR TREATING OF INFECTION BY HELICOBACTER PYLORI COMPRISING CURCUMIN-ENCAPSULATED GINSENOSIDE AND PHOSPHOLIPID-BASED LIPID NANOPARTICLE

COMPOSITIONS FOR PREVENTING OR TREATING OF INFECTION BY HELICOBACTER PYLORI COMPRISING CURCUMIN-ENCAPSULATED GINSENOSIDE AND PHOSPHOLIPID-BASED LIPID NANOPARTICLE

机译：用于预防或治疗幽门螺杆菌的组合物，其包含姜黄素包裹的人参皂苷和磷脂基脂质体

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to a composition for preventing or treating Helicobacter pylori infection, which comprises as an active ingredient ginsenoside and phospholipid-based lipid nanoparticles collected by curcumin. Specifically, the ginsenoside-based and phospholipid-based lipid nanoparticles of the present invention enhanced the solubility and stability of collected curcumin and are excellent in antibacterial activity against Helicobacter pylori. Thus, the present invention is useful for treating infections of Helicobacter pylori .

机译：本发明涉及用于预防或治疗幽门螺杆菌感染的组合物，其包含人参皂苷和姜黄素收集的磷脂基脂质纳米颗粒作为活性成分。具体地，本发明的基于人参皂苷和基于磷脂的脂质纳米颗粒增强了所收集的姜黄素的溶解性和稳定性，并且对幽门螺杆菌的抗菌活性优异。因此，本发明可用于治疗幽门螺杆菌的感染。

著录项

公开/公告号KR101948407B1

专利类型
公开/公告日2019-02-14

原文格式PDF
申请/专利权人 가천대학교 산학협력단;
展开▼

申请/专利号KR20170009678
发明设计人 유봉규;아제이 비자야쿠마르;정광원;정준원;
展开▼

申请日2017-01-20
分类号A61K9/51;A23L33/10;A61K31/12;A61K47/24;
国家 KR
入库时间 2022-08-21 11:49:10

相似文献

专利
外文文献
中文文献

1. Stability and characterisation of phospholipid-based curcumin-encapsulated microemulsions [J] . Chuan-Chuan Lin, Hung-Yin Lin, Hsu-Chih Chen, Food Chemistry . 2009,第4期

2. Cost‐effectiveness analysis of screen‐and‐treat strategy in asymptomatic Chinese for preventing Helicobacter pylori‐Helicobacter pylori‐ associated diseases [J] . Chen Qi, Liang Xiao, Long Xiaohua, Helicobacter . 2019,第2期

3. BROCCOLI SPROUT EXTRACT CONTAINING SULFORAPHANE (BSES) CAN PREVENT LIPID PEROXIDATION IN THE GASTRIC MUCOSA WITH HELICOBACTER PYLORI INFECTION [J] . Chang Y. W., Byun J., Jang J. Y., Helicobacter . 2015,第S1期

4. Design of pH Measuring in Wireless Therapy Capsule Against Helicobacter Pylori Infections [C] . Binbin Ren, Haiyan Tan, Binlin Chen, International Conference on Machinery, Materials and Computing Technology . 2016

5. Analysis of mucin oligosaccharides in the rhesus monkey stomach after Helicobacter pylori infection and transcriptional modulation of outer membrane protein expression in Helicobacter pylori [D] . Cooke, Cara Lea 2008

6. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment—Helicobacter pylori positive (CADET-Hp) randomised controlled trial [O] . Naoki Chiba, Sander J O Veldhuyzen van Zanten, Paul Sinclair, 2002

7. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment---Helicobacter pylori positive (CADET-Hp) randomised controlled trial [O] . N. Chiba 2002

1. Impact of iHelicobacter pylori/iInfection on Serum Lipid Profile and Atherosclerosis of Carotid Artery [J] . Hadeel A. Ibrahim ,Mohammed O. Mohammed ,Hawa A. R. Dhahir . 临床医学国际期刊（英文） . 2014,第15期

2. A systematic review of treating Helicobacter pylori infection with Traditional Chinese Medicine [J] . Jiang Lin Wei-Wen Huang . 世界胃肠病学杂志：英文版 . 2009,第37期

3. Diagnosis of Helicobacterpyloriinfection and diseases associated with Helicobacter pylori by Helicobacter pylori outer membrane proteins [J] . ZhengJiang ,Ai-LongHuang ,Xiao-HongTao . 世界胃肠病学杂志：英文版 . 2004,第23期

4. Accuracy of Helicobacter pylori stool antigen for the detection of Helicobacter py/ori infection in dyspeptic patients [J] . Ari Fahrial Syam ,Abdul Aziz Rani ,Murdani Abdullah . 世界胃肠病学杂志：英文版 . 2005,第3期

5. Reviews of Research on the Relationship between Oral Helicobacter pylori and H. pylori Infection [J] . Lingling Zu . 国际感染杂志（电子版） . 2016,第001期

6. 幽门螺杆菌尿素酶B亚单位融合肽脂质体疫苗及其免疫预防与治疗作用 [C] . 赵文锋 ,吴梧桐 ,徐旭东 . 沪、苏、闽暨全军生物技术药物研讨会 . 2007

7. 长循环脂质体联合磷脂复合物及磷酸钙包裹的介孔二氧化硅在抗肿瘤治疗中的应用 [A] . 吴泓杰 . 2016